세계의 소변 검사 시장 : 제품별, 검사 유형별, 용도별, 최종 용도별 - 예측(2025-2030년)

The Urinalysis Market was valued at USD 4.30 billion in 2023, expected to reach USD 4.53 billion in 2024, and is projected to grow at a CAGR of 5.76%, to USD 6.37 billion by 2030.

Urinalysis encompasses a broad scope as both a critical diagnostic tool and a routine health check method, focusing on the examination of urine for medical assessment and disease monitoring. This process is essential for the early detection of diseases such as diabetes, kidney disorders, and urinary tract infections, contributing to preventive healthcare. The application spans across hospitals, diagnostic laboratories, and home-use settings, making it versatile and widely used across various demographics. The necessity of urinalysis stems from its non-invasive nature, ease of execution, and ability to provide a wealth of vital health information. Market insights reveal that the growth of this sector is primarily driven by the rising incidence of chronic diseases, increased awareness about preventive healthcare, and technological advancements in diagnostic methods. The advent of portable and minimally invasive urinalysis testing kits represents significant potential opportunities, catering to increasing demand for home-based monitoring solutions. However, market limitations include the potential for inaccurate results and the need for cross-verification with more sophisticated diagnostic tools, adding layers of complexity to use and interpretation. Furthermore, challenges such as stringent regulatory requirements and a lack of standardization can impede market growth. Areas ripe for innovation include the development of more accurate, personalized urinalysis tests through artificial intelligence and machine learning algorithms, and the integration of Internet of Things (IoT) connectivity to enhance real-time data monitoring and patient engagement. The nature of the urinalysis market is dynamic, with a steady shift towards patient-centric care, driven by technology and consumer demand for more accessible health insights. Companies aiming to capitalize on these trends should prioritize research into making urinalysis more user-friendly and accurate, while also working towards regulatory harmonization to overcome barriers and expand their market reach.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Urinalysis Market

The Urinalysis Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing prevalence of kidney diseases and urinary tract infections worldwide
  • Favorable government initiatives for early screening and management of chronic diseases
  • Rising adoption of point-of-care urinalysis systems in clinical laboratories and hospitals
• Market Restraints
  • Significant concern for product recall
• Market Opportunities
  • Technological advancement in renal biomarker and smaRT-LAMP system
  • Emergence of automated analyzers for urinary tract infection screening
• Market Challenges
  • Lack of awareness about routine health checkup and limited skilled laboratory workforce

Porter's Five Forces: A Strategic Tool for Navigating the Urinalysis Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Urinalysis Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Urinalysis Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Urinalysis Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Urinalysis Market

A detailed market share analysis in the Urinalysis Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Urinalysis Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Urinalysis Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Urinalysis Market

A strategic analysis of the Urinalysis Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Urinalysis Market, highlighting leading vendors and their innovative profiles. These include 77 Elektronika Kft., Abbott Laboratories, ACON Laboratories, Inc. by Inverness Medical, AdvaCare Pharma, Alphatec Scientific E.I.R.L., Analyticon Biotechnologies GmbH by BRAIN Biotech AG, Anamol Laboratories Pvt. Ltd., ARKRAY, Inc., Beckman Coulter, Inc. by Danaher Corporation, Becton, Dickinson, and Company, Bio-Rad Laboratories, Inc., Bioway Biotechnology Co., Ltd., Cardinal Health, Inc., Contec Medical Systems Co., Ltd., Dirui Industrial Co., Ltd., EKF DIAGNOSTICS HOLDINGS PLC, Erba Group, F. Hoffmann-La Roche Ltd., Kova International, Inc. by LGC Limited, MACHEREY-NAGEL GmbH & Co. KG, Medsource Ozone Biomedicals Pvt. Ltd., Quidel Corporation, Randox Laboratories Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Siemens Healthcare GmbH, Sweet Cures Nutra, Sysmex Corporation, Teco Diagnostics, Thermo Fisher Scientific Inc., URIT Medical Electronic Group Co., Ltd, and Woodley Equipment Company Ltd..

Market Segmentation & Coverage

This research report categorizes the Urinalysis Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Consumables and Instruments. The Consumables is further studied across Collection Cups, Reagents, and Urine Strips/Dipsticks.
• Based on Test Type, market is studied across Biochemical Urinalysis, Pregnancy & Fertility Tests, and Sediment Urinalysis.
• Based on Application, market is studied across Diabetes, Hypertension, Kidney Diseases, Liver Diseases, and Urinary Tract Infections.
• Based on End-Use, market is studied across Clinical Laboratories, Home Healthcare, Hospitals, and Research & Academics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing prevalence of kidney diseases and urinary tract infections worldwide
    • 5.1.1.2. Favorable government initiatives for early screening and management of

chronic diseases

• 5.1.1.3. Rising adoption of point-of-care urinalysis systems in clinical laboratories and hospitals
• 5.1.2. Restraints
  • 5.1.2.1. Significant concern for product recall
• 5.1.3. Opportunities
  • 5.1.3.1. Technological advancement in renal biomarker and smaRT-LAMP system
  • 5.1.3.2. Emergence of automated analyzers for urinary tract infection screening
• 5.1.4. Challenges
  • 5.1.4.1. Lack of awareness about routine health checkup and limited skilled laboratory workforce
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Extensive use of collection cups for the simple and hygienic collection of urine samples for medical diagnostics
  • 5.2.2. End-Use: Increasing use in clinical laboratories for screening and diagnosing various disorders
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Urinalysis Market, by Product

• 6.1. Introduction
• 6.2. Consumables
  • 6.2.1. Collection Cups
  • 6.2.2. Reagents
  • 6.2.3. Urine Strips/Dipsticks
• 6.3. Instruments

7. Urinalysis Market, by Test Type

• 7.1. Introduction
• 7.2. Biochemical Urinalysis
• 7.3. Pregnancy & Fertility Tests
• 7.4. Sediment Urinalysis

8. Urinalysis Market, by Application

• 8.1. Introduction
• 8.2. Diabetes
• 8.3. Hypertension
• 8.4. Kidney Diseases
• 8.5. Liver Diseases
• 8.6. Urinary Tract Infections

9. Urinalysis Market, by End-Use

• 9.1. Introduction
• 9.2. Clinical Laboratories
• 9.3. Home Healthcare
• 9.4. Hospitals
• 9.5. Research & Academics

10. Americas Urinalysis Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Urinalysis Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Urinalysis Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. AixMed and CorePlus Collaborate on Innovative Urine Analysis Research
  • 13.3.2. Toyoda Gosei Invests in Yuurea Inc. for Advancement in Urine Analysis Technology
  • 13.3.3. Medtronic's Strategic Initiative to Address Urinary Incontinence with New Venture
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 77 Elektronika Kft.
• 2. Abbott Laboratories
• 3. ACON Laboratories, Inc. by Inverness Medical
• 4. AdvaCare Pharma
• 5. Alphatec Scientific E.I.R.L.
• 6. Analyticon Biotechnologies GmbH by BRAIN Biotech AG
• 7. Anamol Laboratories Pvt. Ltd.
• 8. ARKRAY, Inc.
• 9. Beckman Coulter, Inc. by Danaher Corporation
• 10. Becton, Dickinson, and Company
• 11. Bio-Rad Laboratories, Inc.
• 12. Bioway Biotechnology Co., Ltd.
• 13. Cardinal Health, Inc.
• 14. Contec Medical Systems Co., Ltd.
• 15. Dirui Industrial Co., Ltd.
• 16. EKF DIAGNOSTICS HOLDINGS PLC
• 17. Erba Group
• 18. F. Hoffmann-La Roche Ltd.
• 19. Kova International, Inc. by LGC Limited
• 20. MACHEREY-NAGEL GmbH & Co. KG
• 21. Medsource Ozone Biomedicals Pvt. Ltd.
• 22. Quidel Corporation
• 23. Randox Laboratories Ltd.
• 24. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• 25. Siemens Healthcare GmbH
• 26. Sweet Cures Nutra
• 27. Sysmex Corporation
• 28. Teco Diagnostics
• 29. Thermo Fisher Scientific Inc.
• 30. URIT Medical Electronic Group Co., Ltd
• 31. Woodley Equipment Company Ltd.